Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
PreveCeutical Medical Inc. (PRVCF) had Consolidated Net Income/Loss of $-0.53M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-0.53M |
|
-- |
|
-- |
|
$0.47M |
|
$-0.47M |
|
$-0.06M |
|
$-0.53M |
|
$-0.53M |
|
$-0.53M |
|
$-0.53M |
|
|
Consolidated Net Income/Loss |
$-0.53M |
$-0.53M |
|
$-0.47M |
|
$-0.47M |
|
536.11M |
|
536.11M |
|
$-0.00 |
|
$-0.00 |
|
| Balance Sheet Financials | |
$0.07M |
|
$0.00M |
|
$0.11M |
|
$0.18M |
|
$5.16M |
|
$0.04M |
|
$0.04M |
|
$5.21M |
|
$-5.03M |
|
$-5.14M |
|
$-5.03M |
|
545.70M |
|
| Cash Flow Statement Financials | |
$-0.07M |
|
$-0.04M |
|
$0.08M |
|
$0.04M |
|
$0.00M |
|
$-0.04M |
|
$0.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.01 |
|
-- |
|
-- |
|
-0.01 |
|
-0.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
10.58% |
|
10.35% |
|
-294.63% |
|
10.67% |
|
$-0.01 |
|
$-0.00 |
|
$-0.00 |
|